Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Cardiome Pharma Corp    COM   CA14159U3010

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
02/05/2016 02/08/2016 02/10/2016 02/11/2016 02/12/2016 Date
7.79 7.53 7.59 6.85 6.85 Last
1200 1115 3800 2600 3345 Volume
-2.63% -3.34% +0.80% -9.75% 0.00% Change
Financials ( CAD)
Sales 2015 34,9 M
EBIT 2015 -23,5 M
Net income 2015 -22,9 M
Debt 2015 -
Yield 2015 -
Sales 2016 48,4 M
EBIT 2016 -17,9 M
Net income 2016 -14,1 M
Debt 2016 -
Yield 2016 -
P/E ratio 2015 -
P/E ratio 2016
Capi. / Sales 2015 3,86x
Capi. / Sales 2016 2,79x
Capitalization 135 M
More Financials
Company
Cardiome Pharma Corp. is a specialty pharmaceutical company, which engages in the discovery, development and commercialization of cardiovascular therapies that will improve the health of patients suffering from heart disease.Cardiome has two marketed, in-hospital, cardiology products, BRINAVESS,... 
Sector
Pharmaceuticals
Calendar
03/10Earnings Release
More about the company
Surperformance© ratings of Cardiome Pharma Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on CARDIOME PHARMA CORP
02/10 CARDIOME PHARMA : To Present At The 5th Annual Leerink Partners Global Healthcar..
01/27 CARDIOME PHARMA : Announces Filing of Orphan Drug Application for Oral Vernakala..
01/21 CARDIOME PHARMA : Announces the Launch of ESMOCARD LYO in Belgium
01/13 CARDIOME PHARMA : announces filing of marketing authorization application for in..
01/12 CARDIOME PHARMA : Announces Share Purchase Agreement with Lincoln Park Capital F..
01/06 CARDIOME PHARMA : and SteadyMed Announce Decision for Centralized Review of Trev..
01/05 CARDIOME PHARMA : Enters Commercialization Agreement with Chong Kun Dang for BRI..
2015 CARDIOME PHARMA : Files New Drug Submission Seeking Canadian Approval of intrave..
More news
Sector news : Biopharmaceuticals
02/13 NOVO NORDISK A/S : Proposed changes in composition of the Board of Directors of ..
02/12 AMGEN : Mystery cannabis 'consortium' reportedly interested in Longmont's Amgen ..
02/12DJSHIRE : Files 8K - Other Events
More sector news : Biopharmaceuticals
News from SeekingAlpha
01/12 Cardiome inks $20M share purchase deal with Lincoln Park Capital
01/06 EMA to review Cardiome's Trevyent MAA under streamlined centralized procedure
2015 PREMARKET BIOTECH DIGEST : Harvoni's Label Expansion, AstraZeneca's Tagrisso App..
2015 Cardiome Pharma's (CRME) CEO William Hunter on Q3 2015 Results - Earnings Cal..
2015 Cardiome Pharma reports Q3 results


Comments 
Advertisement
Chart CARDIOME PHARMA CORP
Duration : Period :
Cardiome Pharma Corp Technical Analysis Chart | COM | CA14159U3010 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions